June 10 (Reuters) - Humana said on Wednesday it has

agreed to sell all or substantially all of its minority stake in

Gentiva, a provider of hospice and palliative care services, in

a deal valuing the stake at about $900 million.

* The stake will be sold to a group of investors, Humana

said, without disclosing other financial terms.

* Humana plans to use the proceeds for general corporate

purposes and said the deal is not expected to affect its 2026

earnings.

* The transaction is expected to close in the third quarter

of 2026, subject to regulatory approvals and other closing

conditions.

* Gentiva provides hospice care and support for seriously

ill patients at more than 430 locations in 35 states.

* Humana's Gentiva stake stems from its 2021 Kindred at Home

deal, after which it said it would sell non-core hospice and

personal care businesses.

* In 2022, Humana sold a majority stake in Kindred at Home's

hospice and personal care units to private equity firm Clayton,

Dubilier & Rice.

(Reporting by Kunal Das in Bengaluru)